A detailed history of Bridgeway Capital Management, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 169,467 shares of NKTX stock, worth $423,667. This represents 0.02% of its overall portfolio holdings.

Number of Shares
169,467
Previous 169,467 -0.0%
Holding current value
$423,667
Previous $1 Million 23.58%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$5.59 - $15.71 $1.17 Million - $3.3 Million
-210,000 Reduced 55.34%
169,467 $1.83 Million
Q4 2023

Feb 14, 2024

SELL
$1.31 - $6.6 $295,667 - $1.49 Million
-225,700 Reduced 37.3%
379,467 $2.5 Million
Q3 2023

Nov 14, 2023

BUY
$1.39 - $2.29 $681,332 - $1.12 Million
490,167 Added 426.23%
605,167 $841,000
Q2 2023

Aug 14, 2023

BUY
$2.19 - $5.17 $251,850 - $594,550
115,000 New
115,000 $251,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $122M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.